2013 annual financial data
ProQR Therapeutics 2013 Net margin
Direct answer
Net margin was -2,033.13%.
Operating income was -3,239,000 EUR and net income was -3,253,000 EUR.
Operating cash flow was -2,332,000 EUR.
Get free ProQR Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 160,000 EUR
- Operating income
- -3,239,000 EUR
- Net income
- -3,253,000 EUR
- Operating cash flow
- -2,332,000 EUR